Journal: Translational Lung Cancer Research
Article Title: A public data-based molecular classification of small cell lung cancer by neuroactive signaling networks unveils distinct microenvironment landscapes and immunotherapy-related prognostic biomarkers
doi: 10.21037/tlcr-2025-620
Figure Lengend Snippet: Identification of prognostic genes in NRS and Validation. (A) Forest plot shows prognosis-associated genes within NRS. (B) In George’s cohort, the distribution of high and low expression of NPPC. Cutting off value was determined using the survminer R package. High expression level of NPPC is associated with poor patient prognosis. (C,D) t-SNE visualization of cells shows the expression of NPPC and its receptor NPR2 in single-cell RNA-seq data. (E) Representative areas of HE and IHC of NPPC expression in tumorous tissues from three SCLC patients. Scale bar, 50 µm. (F-G) qPCR validation of NPPC and NPR2 expression across various human normal epithelial and SCLC cell lines. (H) Transwell migration assay of SCLC-1 cells treated with CNP-38 (product of the NPPC gene) or DMSO (control) for 12 hours (0.5% crystal violet dye, ×100). (I) Data processing and analysis of transwell migration assay. ***, P<0.001; CI, confidence interval; CNP, C-type natriuretic peptide; DMSO, dimethyl sulfoxide; HE, hematoxylin and eosin staining; IHC, immunohistochemistry; NPPC, natriuretic peptide C; NPR2, natriuretic peptide receptor B; NRS, nomogram/prognostic risk score; qPCR, quantitative polymerase chain reaction; RNA-seq, ribonucleic acid sequencing; SCLC, small cell lung cancer; t-SNE, t-distributed stochastic neighbor embedding.
Article Snippet: Human SCLC cell lines (H446, H146, H1688, H526), human normal bronchial epithelial cell lines (16HBE, BEAS-2B), human lung adenocarcinoma cell line (A549), and human large cell lung cancer cell line (H460) were purchased from the American Type Culture Collection (ATCC, RRID: CVCL_1562 for H446, CVCL_1473 for H146, CVCL_1487 for H1688, CVCL_1569 for H526, CVCL_0021 for 16HBE, CVCL_0168 for BEAS-2B, CVCL_0023 for A549, and CVCL_0459 for H460).
Techniques: Biomarker Discovery, Expressing, RNA Sequencing, Transwell Migration Assay, Control, Staining, Immunohistochemistry, Real-time Polymerase Chain Reaction, Sequencing